Lupin competitive analysis

Latest publications and patents of Lupin New

Explore the latest publications and patents granted to Lupin, showcasing their recent innovations and technological advancements.

Last updated on: Sep 27, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Lupin

Oct 16, 2019Modified Release Formulation Of LacosamideOpposition Rejected

Explore patent oppositions filed by Lupin against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 2, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Formoterol Superfine FormulationCHIESI FARMACEUTICIApr 23, 2020
Use Of A Composition Comprising Formoterol And Beclometasone Dipropionate For The Prevention And/Or Treatment Of An Exacerbation Of AsthmaCHIESI FARMACEUTICIMar 12, 2020

Explore Lupin's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
Oct 16, 2019Modified Release Formulation Of Lacosamide1

Latest PTAB cases involving Lupin

Discover the latest PTAB cases involving Lupin, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 3, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Lupin

IPR2021-00326Dec 15, 2020LUPINAMGENInstitution Denied
IPR2018-00459Jan 12, 2018LUPINHORIZON THERAPEUTICSTerminated-Settled
IPR2017-01159Mar 27, 2017LUPINHORIZON THERAPEUTICSTerminated-Settled
IPR2017-01160Mar 27, 2017LUPINHORIZON THERAPEUTICSTerminated-Settled
IPR2016-00829Apr 1, 2016LUPINHORIZON THERAPEUTICSFinal Written Decision
IPR2016-00558Feb 3, 2016LUPINVERTEX PHARMACEUTICALS INCORPORATEDFinal Written Decision
IPR2016-00399Dec 28, 2015LUPIN PHARMACEUTICALSICEUTICAInstitution Denied
IPR2016-00397Dec 28, 2015LUPIN PHARMACEUTICALSICEUTICAInstitution Denied
IPR2016-00283Dec 4, 2015LUPIN PHARMACEUTICALSHORIZON THERAPEUTICSFinal Written Decision
IPR2016-00284Dec 4, 2015LUPIN PHARMACEUTICALSHORIZON THERAPEUTICSFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Lupin with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
LUPIN HEALTHCARE UK2 - - - Highly Aggressive
CHIESI FARMACEUTICI618 - - Balanced